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a b s t r a c t
Phosphatidylinositol 4-phosphate 5-kinase Ic (PIP5KIc) is subject to extensive C-terminal splice varia-
tion, with four variants, PIP5KIc_v1, 2, 4 and 5, described in humans Schill and Anderson (2009) [7]. Here
ﬁrstly, we report a new rodent splice variant, which includes the exon that was previously unique to the
rodent neuron-speciﬁc PIP5KIc93 Giudici et al. (2006) [6], but which omits the C-terminal exon of
PIP5KIc93; this new variant shows a wide tissue expression pattern in mouse. Secondly, we show that
in humans there is an alternative splicing site 78 nucleotides from the start of exon 16c, such that
humans additionally express both PIP5KIc93 (which we now call PIP5KIc_v3) speciﬁcally in brain and,
again expressed more widely, the new variant described here, which we now name PIP5KIc_v6.
 2011 Elsevier Inc.
1. Introduction
The synthesis of PI(4,5)P2 by Type I PtdIns4P 5-kinases (PIP5-
KIs) is the major route by which eukaryotes synthesise this
multi-functional lipid. In addition to its obvious function as the
precursor for both the PI-PLC and receptor-regulated PI 3-kinase
pathways, PI(4,5)P2 has numerous other roles in its own right
in, for example, secretion, endocytosis, F-actin and ion channel
regulation [1,2]. Thus the regulation of the activity and localisa-
tion of the family of PIP5KIa, -Ib and -Ic, is inevitably going to
be complex and sophisticated. The increasing complexity of
regulatory mechanisms during evolution is aided by the appear-
ance of splice variation, as it provides a greater variety of protein
species independently of gene number [3]. PIP5KIs are no
exception, with PIP5KIc being the clearest example.
Ishihara et al. ﬁrst cloned PIP5KIc and showed that it has two
splice variants with different C-termini, which they called A and
B [4] (later known as Ic87 and Ic90, or Ic635 and Ic661). We pre-
viously described the discovery in a rat hippocampal cDNA library
and the initial characterisation, including potential functions, of a
new splice variant of PIP5KIc [5], PIP5KIcC, since referred to as
Ic93 [6] (see Fig. 1A). A recent publication reported two further
splice variants of PIP5KIc speciﬁc to humans with unique
C-termini largely unrelated to any of the above variants [7]. Both
of these are also based on the Ic87 core (see Fig. 1B – note that a
different exon numbering system is used in humans). Apparently
neither of these variants incorporates the exon homologous to
rat 17, which is unique to Ic93. Schill and Anderson [7] discussed
the possibility that Ic93 might be expressed in humans, and that
because their new human variant Ic_v5 is similar in the ﬁrst part
of its insert sequence to the Ic93 insert, Ic_i5 might replace the
speciﬁc function of Ic93 in non-neuronal tissues.
In this paper, ﬁrstly we report the discovery of a new splice var-
iant in rodents, and secondly we demonstrate that both PIP5KIc93
(now PIP5KIc_v3, as suggested in Ref. [7] – see below) and this new
variant are present in humans.
2. Materials and methods
2.1. RNA extraction and puriﬁcation from the pituitary
Prior to the experiment, glass equipment was incubated in
diethyl pyrocarbonate (DEPC, Sigma) overnight at 37 C, followed
by autoclaving. Other non-disposal equipment was cleaned using
RNaseZAP (Sigma). Fresh or frozen (in RNAlater RNA stabilisation
reagent, QIAGEN) pituitary tissues were homogenised in a Dounce
homogeniser, using the RNeasy mini kit (QIAGEN). RNA yield was
determined by spectrophotometry.
2.2. Reverse-transcription PCR
Access RT-PCR system (Promega) was used, with speciﬁc prim-
ers, to amplify the region of interest from RNA. Basic PCR and
RT-PCR were carried out in one thermal reaction to produce
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Fig. 1. Splicing and exon patterns in human and rat. (A) Splicing patterns of PIP5KIc
in rat, including the new nomenclature from humans [7]. Equivalent human exon
numbering is included for comparison. Note that the stop codon common to all
these variants at the beginning of (rat) exon 19 is not shown. (B) Splicing patterns of
PIP5KIc in humans (adapted from Schill and Anderson [7]). (C) Amino acid
sequences of human Ic_i5-speciﬁc insert (B and Ref. [7]) with the homologous rat
and mouse sequences below. The extra splice site that is used to generate human
Ic_i3 and Ic_i6 (see text) is arrowed.
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either from tissue extraction (see above) or commercially (mouse
total RNA, Ambion). Primers were designed to span the junctions
of two adjacent exons of the target, where possible, in order to avoid
any potential contamination fromgenomicDNA. The pair of primers
are designed to have similar GC content (>40%) and Tm (>78 C).
2.3. Polymerase chain reaction
PCR primers were designed for rat, mouse or human as dictated
by the cDNA library being probed, and are indicated schematically
on each ﬁgure. The hippocampal and mouse tissue cDNA libraries
were as described in Ref. [5]. The human templates were obtained
commercially from Origene (First Strand cDNA of human tissues,
Set 1).
Polymerase chain reaction (PCR) was performed using Taq DNA
polymerase (Sigma) together with Pfu Turbo DNA polymerase
(Stratagene) in a 4:1 M ratio. For a 50 ll reaction, 1 ll (5 U) of en-
zyme was supplemented with 50 ng DNA template, 10 lM of each
primer, 200 lM dNTPs and 1 reaction buffer (50 mM KCl, 20 mM
Tris–HCl pH 8.3). A typical thermal cycle consisted of 2 min at
95 C, 25–30 cycles of 30 s at 95 C, 1 min at 55 C and 1 min at
72 C. This was followed by 5 min at 72 C, and 4 C thereafter.Typical primer pairs were designed to be 18–22 bp in length, with
a GC content of 50–60% and similar Tm, between 55 and 60 C.
Actin controls were included in all experiments to ensure that
the PCR took place. These are not shown in the ﬁgures because
in all of these experiments PI5PKIc-speciﬁc bands were identiﬁed
and sequenced, and these bands in turn serve as positive controls,
so that if another band is absent (e.g. Ic_v3 in tissues other than
brain or embryo – all panels of Fig. 2), this absence is not simply
due to failed PCR.
2.4. Agarose gel electrophoresis
Agarose (0.7–1 g) was resuspended in 100 ml Tris-buffer saline
(TBS, containing 50 mM Tris, 140 mM NaCl, pH 7.5), heated to
dissolve and left to set in the gel tank at room temperature. DNA
samples were loaded near the cathode in the loading dye (2.5% Fi-
coll-400, 11 mM EDTA, 3.3 mM Tris–HCl, 0.017% SDS, 0.015% bro-
mophenol blue). A voltage of typically 80 V was applied till the
blue frontline of the dye ran out of the gel. The separation pattern
of the DNA bands could then be visualised and digitalised under
the UV light.
2.5. Transfection
COS7 cells at 80–90% conﬂuence were transiently transfected
using the FuGene6 transfection reagent (Roche Molecular Bio-
chemicals, USA), 24 h before imaging.
2.6. Live confocal imaging
Cells were imaged in fresh DMEM, either at room temperature
or 37 C. Image acquisition was achieved using a Leica CTR 6500
confocal microscope and Leica Application Suite software (2.4.1
build 6384). An Argon laser at 28 mW provided the source of illu-
mination at 488 nm. A 40, 1.25 NA oil-immersion objective was
used, and GFP-fused kinases were visualised through a
495–535 nm ﬁlter. Images were collected in 1024  1024 pixels,
as an average of 4 scans at 400 Hz.3. Results and discussion
3.1. A new splice variant of PIP5KIc in rodents
In situ hybridisation originally revealed that PIP5KIc93 (now
called Ic_v3, see below) is expressed primarily in neurons [5].
Using the same RNA sequence speciﬁc to the PIP5KIc93/Ic_
v3-speciﬁc exon 17 [5], we extended our in situ hybridisation stud-
ies to other parts of the mouse brain. We observed a strong signal
from pituitary, and when we analyzed by RT-PCR a rat pituitary
mRNA extract using primers speciﬁc for PIP5PIc93/Ic_v3, as well
as the band of MW expected for that spliceoform we found an
additional lower MW band. When sequenced this was found to
be a new PIP5KIc variant in which exon 17 (see Fig. 1A) is included,
but exon 18 is omitted so that the stop codon at the beginning of
exon 19 (also used for Ic_v3 and not shown in Fig. 1A) follows
immediately after exon 17.
3.2. Nomenclature of PIP5KIc splice variants
As exons 17 and 18 are identical in size, this new pituitary splice
variant has the same molecular weight as PIP5K Ic90/PIP5KIc661
(human PIP5KIc_v2 in Ref. [7]), so naming it in the context of ro-
dent nomenclature would be problematic. However, below we
show that both the new variant and PIP5KIc93 are expressed in
humans. In their re-naming of human PIP5KIc splice variants Schill
Fig. 2. PCR ampliﬁcation of human and rodent cDNA libraries. Primers used for A–D are depicted schematically (not to scale) below each ﬁgure. Note the different exon
numbering in human versus rodent (see also Fig. 1A). For C and D (human) the alternative splice site within exon 16c that generates Ic_v3 and Ic_v6 (see Fig. 1C and text) is
indicated by ‘splice’. The stop codon that ends Ic_v5 (see Ref. [7]) is also indicated in brackets. (A) Rat hippocampal cDNA library [5] using rat-speciﬁc primers. (B) Mouse
tissues total mRNA library [5] using mouse-speciﬁc primers O, ovary; T, testis; Y, thymus; H, heart; L, lung; R, liver; S, spleen; K, kidney; E, embryo; B, brain. The prominent
band in heart was sequenced and is not a PIP5KI. (C) Human tissues cDNA library using human-speciﬁc primers. B, brain; H, heart; K, kidney; S, spleen; R, liver; L, leukocytes.
Note that the lower band in brain and kidney is not Ic_v6, but Ic_v2 (see text). (D) Human tissues cDNA library using human-speciﬁc primers. For lettering see (C).
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found to be present in humans [7]. So we propose to follow their
lead and use the name PIP5KIc_v3 (abbreviated here to Ic_v3)
for PIP5KIc93. Adopting this nomenclature then leads logically to
calling our new variant PIP5KIc_v6 (abbreviated to Ic_v6). Note
that we also follow Ref. [7] by using v for the nucleic acid (e.g.
Ic_v6) and i for the protein (e.g. Ic_i6).3.3. Pattern of PIP5KIc_v6 expression
The PCR primers that we used to scan mouse tissue mRNA for
the three variants Ic_v1–3 [5] were from exon 16 (forward) to 19
(reverse), and we distinguished the three known spliceoforms on
the basis of the molecular weight of the products [5]. However,
as discussed above, Ic_v2 would yield a product of exactly the
Fig. 3. Localisation of expressed proteins. Representative images of COS cells
transfected with GFP-tagged Ic_i2 and Ic_i6 (duplicates shown in each row).
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whole issue of spliceoform distribution now needs re-examination
with more speciﬁc primers and sequencing.
We therefore ﬁrst re-analyzed the rat hippocampal cDNA li-
brary from which we originally cloned Ic_v3 [5] with primers spe-
ciﬁc for each spliceoform (the primers used for Ic_v6 will also
amplify Ic_v3). Fig. 2A shows that as we found before [5], Ic_v1,
2 and 3 are all expressed in rat hippocampus. However, Ic_v6 is
not detectable in hippocampus; the very high MW band in lane 2
is not a PIP5KI, and the lower band was sequenced and conﬁrmed
to be from Ic_v3.
We next did a full analysis of rat pituitary cDNA using the same
primers and sequencing all the bands, and this revealed that pitu-
itary expresses Ic_v1, Ic_v3 and Ic_v6, but no detectable Ic_v2 (not
shown). We also analyzed the mouse pituitary cell line AtT-20 with
the equivalent mouse-speciﬁc primers, and found a similar pattern
of expression with again the notable absence of Ic_v2. This latter
variant is generally thought to be the most ubiquitously expressed
of the PIP5KIc spliceoforms, but its identiﬁcation might sometimes
have been complicated by the presence of Ic_v6. To gain some in-
sight into the expression pattern of Ic_v6, we therefore re-
analyzed the mouse tissue mRNA library that we previously used
to explore tissue distribution of PI5PIc variants [5], but using
mouse Ic_v3/6-speciﬁc primers. The data (Fig. 2B) conﬁrm the high
expression of Ic_v3 in brain and its apparent absence in other tis-
sues [5]. Lower MW bands, suggested to be Ic_v6 on the basis of
their MW, were detected in all tissues, and those bands from heart,
liver, spleen and kidney were all sequenced and conﬁrmed as being
Ic_v6. Overall these data suggest expression of Ic_v6 in all the
samples that are included in the library, implying that this spliceo-
form has a wide tissue distribution.
3.4. Human splicing
3.4.1. Human PIP5KIc_v3
Schill and Anderson [7] pointed out that the insert speciﬁc to
human Ic_i5 (exon 16c – see Fig. 1B) begins with a sequence of
amino acids 75% identical to the Ic_i3-speciﬁc 26 amino acids
coded for by rat exon 17. In fact comparing the human and rat se-
quences reveals that the ﬁrst 26 amino acids of the equivalent rat
sequence is actually the Ic_i3-speciﬁc insert (Ref. [5], see Fig. 1C).
Thus Ic_v3 could be conserved in humans if there was an alterna-
tive splicing after the 78 nucleotides coding for these 26 amino
acids, such that the remainder of the exon 16c after these nucleo-
tides up to the stop codon identiﬁed by Schill and Anderson [7]
(see Fig. 1B and C) is either part of an exon (in Ic_v5) or an intron
(in Ic_v3). This is very plausible because the human sequence here
is ACTGTAAGT, where the ACT is the threonine codon that would
end a human Ic_v3 26 amino acid insert (arrow in Fig. 1C), and
GTAAGT is a well documented 50 alternative splice site consensus
sequence [8,9]. We therefore tried to amplify Ic_v3/6 from a
human brain cDNA library from Origene (not shown) and also a hu-
man tissue cDNA library from Origene (see Section 2) that included
brain (Fig. 2C). In both we found that the lower MW band in brain
(and kidney, Fig. 2C) when sequenced was not Ic_v6, but Ic_v2,
which we presume was ampliﬁed by some cross-
hybridisation of the 16a/16c forward primer. However, the strong
band consistent with Ic_v3 by MW (Fig. 2C) was excised and con-
ﬁrmed by sequencing to be Ic_v3, from which we conclude that
humans do indeed express Ic_v3.
3.4.2. Human PIP5KIc_v6
We then re-analyzed the human brain cDNA library with new
primers (see Fig. 2D, the forward primer is within the 16c exon
to avoid the spurious Ic_v2 ampliﬁcation) but were not able to de-
tect Ic_v6, only Ic_v3 (not shown). This suggests that, consistentwith the above data from mouse and rat, Ic_v6 is not a major brain
variant. Finally we used these primers on the human tissue cDNA
library (Fig. 2D), and the lower MW bands from all the tissue lanes
in Fig. 2D were sequenced and conﬁrmed as being Ic_v6 (note that
in this library some Ic_v6 is detected in brain, which may reﬂect
different representation between libraries of regions such as pitu-
itary, which is particularly Ic_v6-rich). So, as in the mouse, in hu-
mans Ic_v6 is apparently widespread in its distribution, while
Ic_v3 (again conﬁrmed by sequencing of the higher MW band in
Fig. 2D) is more brain-speciﬁc.
Thus overall we conclude that in humans there is an alternative
splice site 78 residues into exon 16c that splices out the rest of the
Ic_v5 insert (see Fig. 1C), and then jumps either (a) to the start of
exon 17 (Fig. 1B) to generate human Ic_v3 (the stop codon is then
at the start of human exon 18); or (b) straight to that stop codon in
exon 18 to generate human Ic_v6.3.5. Properties of PIP5KIc_i6
The protein Ic_i3 differs from Ic_i1 and Ic_i2 (and Ia and Ib) in
that when transfected into COS cells it is not plasma membrane-
localised but largely intracellular [6]. Moreover, in HEK cells
Ic_i3 is on or near the plasma membrane, but unlike Ic_i1 and
Ic_i2, it shows a large immobile fraction when analyzed by FRAP
[6]. We do not yet understand the physiological signiﬁcance of
these empirical differences between transfected proteins, but to
gain preliminary insight into Ic_i6’s properties, we generated
Ic_i6 by introducing a stop codon into our GFP-tagged Ic_v3 con-
structs immediately after the 26 amino acid insert, and then re-
peated these protocols. Fig. 3 shows that in COS cells the Ic_i6 is
apparently mostly plasma membrane-localised, and in these
experiments was indistinguishable from Ic_i2. We also found that
in HEK cells Ic_i6 has a FRAP proﬁle indistinguishable from Ic_i2
(not shown).
Finally, we generated an antibody to the 26 amino acid insert
speciﬁc to Ic_i3 and Ic_i6, which speciﬁcally recognised these vari-
ants by both immunocytochemistry and Western blotting when
they were transfected into cells. However, this antibody did not
immunoprecipitate either splice variant, and moreover it did not
show sufﬁcient speciﬁcity or afﬁnity to recognise unambiguously
by Western blotting the endogenous proteins in tissue extracts of
kidney or pituitary. The antibody also could not localise Ic_i6 with-
in kidney slices prepared as in Ref. [10], despite the apparent pres-
ence of the RNA in this tissue (Fig. 2B). A fuller understanding of
420 Y. Xia et al. / Biochemical and Biophysical Research Communications 411 (2011) 416–420the endogenous Ic_i6 protein must therefore await better
antibodies.
In conclusion, as we have discussed above, the existence of
Ic_v6 may be a complicating factor in studies which have investi-
gated the distribution of Ic_v2 if its presence is based on the MW of
PCR products using primers such as those we used previously [5].
More importantly, our discovery of a sixth splice variant in humans
of a PIP5KIc that is similar to Ic_v4 and Ic_v5 in its broad expres-
sion pattern [7], but with an apparently different intracellular
localisation from those two variants [7], highlights the diversity
of potential PIP5KIc forms, which is in turn probably a reﬂection
of the remarkable diversity of PI(4,5)P2 functions.
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